🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, mono-center phase I/II study designed to determine t...
Status
Unknown
Location
Charité, university medicine, Berlin, CCM
Start Date
2009-02
Trial ID
NCT00930475
CONTESSA 2 is a multinational, multicenter, Phase 2 study of tesetaxel in p...
Status
Terminated
Location
Innovative Clinical Research Institute
Start Date
2019-02-05
Trial ID
NCT03858972
Treatments Being Tested
This study is a randomized control cross over trial of exercise training du...
Status
Completed
Location
Breast Cancer Training Center, 614 W. 8th Ave
Start Date
2015-08
Trial ID
NCT02473861
Treatments Being Tested
This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Status
Completed
Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Start Date
2022-07-05
Trial ID
NCT05415215
In metastatic breast cancer (MBC) patients who have already received anthra...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT01091168
Treatments Being Tested
Human epidermal growth factor receptor 2 (HER2) positive breast cancer is a...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2015-01-01
Trial ID
NCT06711055
The purpose of this study is to assess the efficacy, tolerability, safety, ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-01-25
Trial ID
NCT05114746
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as irinotecan, work in differen...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00275041
Treatments Being Tested
The overall aim of the trial is to evaluate the safety, tolerability, and p...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2020-03-04
Trial ID
NCT04221542
Treatments Being Tested
The purpose of this study is to determine whether * Paclitaxel and bevaciz...
Status
Terminated
Location
GBG Forschungs GmbH
Start Date
2009-07
Trial ID
NCT01200212
Treatments Being Tested